financetom
Business
financetom
/
Business
/
Toyota global output skids in June, dragged down by Japan and China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toyota global output skids in June, dragged down by Japan and China
Jul 29, 2024 10:37 PM

TOKYO (Reuters) - Toyota's ( TM ) global production tumbled in June, down for a fifth straight month with the automaker hit hard by a certification scandal in its home market and a fierce price war in China.

Output worldwide for Japan's biggest automaker slid 12.9% to 795,862 vehicles, the sharpest decline since December 2022.

In its home market, output plunged 18.8% after the transport ministry found irregularities in applications by Toyota ( TM ) and other automakers to certify certain models in a widening of an auto safety scandal.

In China, where domestic electric vehicle makers like BYD have rapidly gained market share and have aggressively cut prices, production fell 21.7% - marking the fifth month in a row where Toyota's ( TM ) output has declined by 20% or more.

Production in North America fell 6.2% while in Europe it dropped 6.6% due to fewer production days compared to last year.

Toyota's ( TM ) worldwide sales fell 5.1% during the month, hurt by declines in Japan and China.

The automaker is due to report first-quarter financial results on Thursday. It is expected to log a 21% rise in operating profit from a year earlier to 1.35 trillion yen ($8.7 billion), according to an LSEG consensus estimates from six analysts, helped by a weaker yen and robust demand for hybrid vehicles in the United States.

During the first six months of this year, the automaker's global production fell 5% while worldwide sales dipped 0.9%.

Both sales and production figures include the luxury Lexus brand.

($1 = 154.0800 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tenet Healthcare's Q1 Adjusted Earnings Rise, Revenue Decreases; 2025 Adjusted EPS Guidance Lifted
Tenet Healthcare's Q1 Adjusted Earnings Rise, Revenue Decreases; 2025 Adjusted EPS Guidance Lifted
May 25, 2025
07:57 AM EDT, 04/29/2025 (MT Newswires) -- Tenet Healthcare ( THC ) reported Q1 adjusted earnings Tuesday of $4.36 per diluted share, up from $3.22 a year earlier. Analysts polled by FactSet expected $3.12. Net operating revenue for the quarter ended March 31 was $5.22 billion, compared with $5.37 billion a year earlier. Analysts surveyed by FactSet expected $5.14 billion....
Trump tariffs force Volvo Cars to drop guidance, launch cost cuts
Trump tariffs force Volvo Cars to drop guidance, launch cost cuts
May 25, 2025
STOCKHOLM (Reuters) -Volvo Cars announced 18 billion Swedish crowns ($1.87 billion) in cost cuts and a restructuring of its U.S. operations on Tuesday and withdrew its earnings forecast for the next two years, sending shares down 10%.  The group, one of the most exposed European automakers to U.S. tariffs as most of the cars it sells there are imported from...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Profound Medical Says Peri-operative Study Backs TULSA Procedure Effectiveness
Profound Medical Says Peri-operative Study Backs TULSA Procedure Effectiveness
May 25, 2025
07:56 AM EDT, 04/29/2025 (MT Newswires) -- Profound Medical ( PROF ) on Tuesday said initial peri-operative data from a trial comparing the safety and efficacy of the company's TULSA procedure with radical prostatectomy showed significantly superior post-treatment patient experience compared to robotic prostatectomy. According to a statement, the data showed that patients who underwent the TULSA procedure to remove...
Copyright 2023-2026 - www.financetom.com All Rights Reserved